The Accuracy and Feasibility of Continuous Glucose Monitoring in COVID-19 Non-Critically Ill Hospitalized Patients: A Pilot Study
- Conditions
- The accuracy and feasibility of real-time continuous glucose monitoring (rt-CGM) in non-ICU hospitalized adult COVID-19 patients who had hyperglycemia requiring insulin therapy during admission.continuous glucose monitoring, COVID-19, accuracy
- Registration Number
- TCTR20230426007
- Lead Sponsor
- Specific League Funds
- Brief Summary
Rt CGM use in hospitalized patients with COVID 19 infection demonstrates high accuracy and potentially improves glucose control, reduces the frequency of CBG testing, and preserves medical resources.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 15
1. Hospitalized patients 18 years old of age or older
2. Positive COVID-19 RT-PCR test
3. Hyperglycemia requiring insulin therapy during admission in non-ICU units 4. Capability to use rt-CGMs and perform self-monitoring of CBG
1. Coagulopathy (INR over 3)
2. Thrombocytopenia (platelet count less than 20,000/uL)
3. Hypotension (defined as BP less than 90/60 mmHg) or poor tissue perfusion
4. Multiorgan failure
5. Significant edema
6. Current treatment with dual antiplatelet therapy or medications known to interfere with the accuracy of CGMs such as hydroxyurea, intravenous ascorbic acid, paracetamol more than 4 grams in 24 hours
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Accuracy of CGM 7 days MARD
- Secondary Outcome Measures
Name Time Method Reduction of point of care blood glucose testing 7 days Times